Studies have shown that GLP-1 agonists can trigger effects in the brain, the heart, the liver, the pancreas, the stomach, and the musclesmeaning that they could have implications for conditions other than type 2 diabetes and obesity, such as heart disease, kidney disease, liver disease, and even neurological conditions such as Alzheimer's disease
VivioMD Group LLC , based at 16192 Coastal Highway, Lewes, DE 19958, is the platform and nonclinical business support layer - the website, intake forms, and customer service
Our mission is to help you embrace a healthier lifestyle through science and empathy
In plain terms, semaglutide makes you eat less
GLP-1 Cost Management, Coverage, and Demand Skyrocketing costs are one challenge
Mental health concerns, including anxiety and depression, especially with semaglutide, were also notable but occurred less often than GI symptoms, with Wegovy showing the highest depression mention rate